Brazilian Journal of Anesthesiology
https://bjan-sba.org/article/doi/10.1016/j.bjane.2018.12.007
Brazilian Journal of Anesthesiology
Scientific Article

Trends in hospital consumption of analgesics after the implementation of a pain performance improvement plan

Tendências no consumo hospitalar de analgésicos após a implantação de plano de melhoria do controle da dor

Beatriz Monje; Álvaro Giménez-Manzorro; Cristina Ortega-Navarro; Ana Herranz-Alonso; María Sanjurjo-Sáez

http://dx.doi.org/10.1016/j.bjane.2018.12.007 Braz J Anesthesiol, vol.69, n3, p.259-265, 2019
PDF English
PDF Português
Downloads: 0
Views: 623

Abstract

Abstract Background: Pain management committee established a pain performance improvement plan in 2012. Objectives: The aim of the study was to assess the trends in analgesic consumption in a tertiary teaching hospital and the associated economic impact. Methods: A descriptive, retrospective study was conducted between 2011 and 2015. The analysis included: anti-inflammatory and antirheumatic products non-steroids, opioid analgesics and other analgesics and antipyretics. Data are converted into DDD/100 bed-days to analyze consumption trends. Main outcome measure: assessment of the analgesic consumption after the implementation of a pain performance improvement plan. Results: Overall, non-steroidal anti-inflammatory and antirheumatic products consumption decreased in 24.8 DDD/100 bed-days (-28.3%), accounting for most of the total analgesic consumption decrease (-13%) and total cost (-44.3%). Opioid consumption increased markedly from 22.3 DDD/100 bed-days in 2011 to 26.5 DDD/100 bed-days in 2015 (+18.9%). In 2011, the most consumed opioid was morphine (8.6 DDD/100 bed-days). However, there was an increasing trend in fentanyl consumption (from 8.1 to 12.1 DDD/100 bed-days in 2015), which resulted in fentanyl replacing morphine from the most consumed opioid in 2015 (12.1 DDD/100 bed-days). In 2015, the group of other analgesics and antipyretics represented 46.2% of the total analgesic consumption. Acetaminophen was the most commonly consumed analgesic drug (53.2 DDD/100 bed-days in 2015) and had the highest total cost, it represented 55.4% of the overall cost in 2015. Conclusion: Opioid consumption showed an increasing trend during the 5 year period, with fentanyl replacing morphine as the most used opioid. In general, analgesics diminished use was due to the decreasing trend of consumption of non-steroidal anti-inflammatory and antirheumatic products.

Keywords

Analgesic, Consumption, Pain, Opioid

Resumo

Resumo Justificativa: A Comissão para o Manejo da Dor estabeleceu um plano de melhoria no controle da dor em 2012. Objetivo: Avaliar as tendências do consumo de analgésicos em um hospital de ensino terciário e o impacto econômico associado. Métodos: Estudo descritivo, retrospectivo, feito entre 2011 e 2015. A análise incluiu: produtos anti-inflamatórios e antirreumáticos não esteroides, analgésicos opioides e outros analgésicos e antipiréticos. Os dados foram convertidos em DDD/100 leitos-dia para analisar as tendências de consumo. Principal medida do desfecho: avaliação do consumo de analgésicos após o estabelecimento de um plano de melhoria no controle da dor. Resultados: O consumo total de produtos anti-inflamatórios e antirreumáticos não esteroides diminuiu em 24,8 DDD/100 leitos-dia (-28,3%), representando a maior parte da redução total do consumo de analgésicos (-13%) e o custo total (-44,3%). O consumo global de opioides aumentou acentuadamente de 22,3 DDD/100 leitos-dia em 2011 para 26,5 DDD/100 leitos-dia em 2015 (+18,9%). Em 2011, o opioide mais consumido foi a morfina (8,6 DDD/100 leitos-dia). No entanto, houve uma tendência crescente no consumo de fentanil (de 8,1 para 12,1 DDD/100 leitos-dia em 2015), o que resultou na substituição de morfina por fentanil como o opioide mais consumido em 2015 (12,1 DDD/100 leitos-dia). Em 2015, o grupo dos outros analgésicos e antipiréticos representou 46,2% do consumo total de analgésicos. Acetaminofeno foi o analgésico mais consumido (53,2 DDD/100 leitos-dia em 2015) e teve o maior custo total, representou 55,4% do custo total em 2015. Conclusão: O consumo de opioides mostrou uma tendência crescente durante o período de cinco anos, fentanil substituiu morfina como o opioide mais usado. Em geral, o uso diminuído de analgésicos foi devido à tendência decrescente do consumo de produtos anti-inflamatórios e antirreumáticos não esteroides.

Palavras-chave

Analgésico, Consumo, Dor, Opioide

References

Treede RD. The Kyoto protocol of IASP basic pain terminology. Pain. 2008;137:473-7.

Wells N, Pasero C, McCaffery M. Improving the quality of care through pain assessment and management. Source patient safety and quality: an evidence-based handbook for nurses. 2008.

Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy. Pain. 1986:S1-S226.

Zin CS, Chen LC, Knaggs RD. Changes in trends and pattern of strong opioid prescribing in primary care. Eur J Pain. 2014;18:1343-51.

Werber A, Marschall U, L’hoest H. Opioid therapy in the treatment of chronic pain conditions in Germany. Pain Phys. 2015;18:E323-31.

Molloy AR, Nicholas MK, Cousins MJ. Role of opioids in chronic non-cancer pain. Med J Aust. 1997;167:9-10.

Cancer pain relief. 1986.

Narcotic and psychotropic drugs: achieving balance in national opioids control policy. Guidelines for assessment. 2000.

Acute pain management: operative or medical procedures and trauma, Part 2. Agency for Health Care Policy and Research. Clin Pharm. 1992;11:391-414.

Gordon DB, Dahl JL, Miaskowski C. American pain society recommendations for improving the quality of acute and cancer pain management: American Pain Society Quality of Care Task Force. Arch Intern Med. 2005;165:1574-80.

World Health Organization Collaborating Centre for Drug Statistics Methodology. .

Spanish government, “Real Decreto-ley 16/2012, de 20 de abril, de medidas urgentes para garantizar la sostenibiliadad del Sistema Nacional de Salud y mejorar la calidad y seguridad de sus prestaciones.”, BOE-A-2012-5403. 2012.

Garcia del Pozo J, Carvajal A, Viloria JM. Trends in the consumption of opioid analgesics in Spain Higher increases as fentanyl replaces morphine. Eur J Clin Pharmacol. 2008;64:411-5.

Utilización de medicamentos opioides en España durante el periodo 2008-2015. U/OPI/V1/13022017. 2017.

Rolland B, Bouhassira D, Authier N. Mésusage et dépendance aux opioïdes de prescription: prévention, repérage et prise en charge. La Rev Médec Intern. 2017;38:539-46.

Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain - United States, 2016. MMWR Recomm Rep. 2016;65:1-49.

Utilización de antiinflamatorios no esteroides (AINE) en España, 1992-2006. 2008.

Seguridad cardiovascular de los AINE tradicionales: conclusiones de la revisión de los últimos estudios publicados, MUH(FV), 15/2012. 2012.

Diclofenaco y riesgo cardiovascular: restricciones de uso, MUH(FV), 16/2013. 2013.

Ketorolaco: cambio a medicamento de uso hospitalario, 2007/02. 2007.

McNicol E, Strassels SA, Goudas L. NSAIDS or paracetamol, alone or combined with opioids, for cancer pain. Cochrane Database Syst Rev. 2005:CD005180.

Ripamonti CI, Santini D, Maranzano E. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol. 2012;23(Suppl. 7):vii139-54.

Simó RM, Seijó F, Esteban MC. Evolución de la utilización de analgésicos en un hospital general. 1986.

Salcedo PG, Ambrosio AH, Muñoz y Ramón JM. Estudio de utilización de analgésicos opiáceos en un hospital general universitario. Rev Soc Esp Dolor. 2009;16:373-80.

5dc5681b0e8825c55e593253 rba Articles
Links & Downloads
2352-2291 (Electronic) 0104-0014 (Printed)
Braz J Anesthesiol ©2024 All rights reserved.

Braz J Anesthesiol

Share this page
Page Sections